MTIF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.03419994790244E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.87040000043659E-07 |
Normal-vs-Stage2 |
2.121600E-03 |
Normal-vs-Stage3 |
2.45419995437146E-09 |
Normal-vs-Stage4 |
2.37479999998236E-07 |
Stage1-vs-Stage2 |
7.664000E-01 |
Stage1-vs-Stage3 |
4.635800E-02 |
Stage1-vs-Stage4 |
1.678610E-01 |
Stage2-vs-Stage3 |
1.034250E-01 |
Stage2-vs-Stage4 |
2.280600E-01 |
Stage3-vs-Stage4 |
7.752800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.60250004774565E-09 |
Normal-vs-AfricanAmerican |
1.37630018492985E-10 |
Normal-vs-Asian |
2.869400E-01 |
Caucasian-vs-AfricanAmerican |
7.920500E-03 |
Caucasian-vs-Asian |
3.590400E-01 |
AfricanAmerican-vs-Asian |
2.965900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.81829995504756E-09 |
Normal-vs-Female |
6.68630000255632E-08 |
Male-vs-Female |
7.048400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.21200000036126E-07 |
Normal-vs-Age(41-60Yrs) |
1.91329999621459E-08 |
Normal-vs-Age(61-80Yrs) |
7.51059999748449E-08 |
Normal-vs-Age(81-100Yrs) |
1.99073999999078E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.049420E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.448000E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.512800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.720200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.144400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.271400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.555600E-03 |
Normal-vs-Grade 2 |
3.5696000000307E-07 |
Normal-vs-Grade 3 |
1.59190000070808E-08 |
Normal-vs-Grade 4 |
1.08530000542117E-08 |
Grade 1-vs-Grade 2 |
8.949200E-01 |
Grade 1-vs-Grade 3 |
8.956200E-01 |
Grade 1-vs-Grade 4 |
3.828600E-01 |
Grade 2-vs-Grade 3 |
4.556800E-01 |
Grade 2-vs-Grade 4 |
3.620000E-02 |
Grade 3-vs-Grade 4 |
1.044040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.762160E-03 |
Normal-vs-ccB subtype |
4.71640504429161E-11 |
ccA subtype-vs-ccB subtype |
2.05389999999861E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.06739999949923E-07 |
Normal-vs-N1 |
1.017980E-01 |
N0-vs-N1 |
7.208400E-01 |
|
|